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Abstract
Few studies have examined therapist effects and therapeutic alliance (TA) in treatments for
chronic fatigue syndrome (CFS). Therapist effects are the differences in outcomes achieved
by different therapists. TA is the quality of the bond and level of agreement regarding the
goals and tasks of therapy. Prior research suffers the methodological problem that the allo-
cation of therapist was not randomized, meaning therapist effects may be confounded with
selection effects. We used data from a randomized controlled treatment trial of 296 people
with CFS. The trial compared pragmatic rehabilitation (PR), a nurse led, home based self-
help treatment, a counselling-based treatment called supportive listening (SL), with general
practitioner treatment as usual. Therapist allocation was randomized. Primary outcome
measures, fatigue and physical functioning were assessed blind to treatment allocation. TA
was measured in the PR and SL arms. Regression models allowing for interactions were
used to examine relationships between (i) therapist and therapeutic alliance, and (ii) thera-
pist and average treatment effect (the difference in mean outcomes between different treat-
ment conditions). We found no therapist effects. We found no relationship between TA and
the average treatment effect of a therapist. One therapist formed stronger alliances when
delivering PR compared to when delivering SL (effect size 0.76, SE 0.33, 95% CI 0.11 to
1.41). In these therapies for CFS, TA does not influence symptomatic outcome. The lack of
significant therapist effects on outcome may result from the trial’s rigorous quality control, or
random therapist allocation, eliminating selection effects. Further research is needed.
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Introduction
Chronic Fatigue Syndrome (CFS), also known as myalgic encephalomyelitis or encephalopathy
(ME), is characterised by severe, disabling fatigue which affects both physical and mental func-
tioning [1]. The most effective treatments for CFS are cognitive behaviour therapy (CBT) and
graded exercise therapy (GET) delivered by expert therapists [2–4]. Pragmatic rehabilitation,
an approach which combines elements of CBT and GET, delivered by trained general nurses
was effective in improving fatigue over an 18-week treatment period but effects attenuated over
one year follow up [5].
Identifying the components of therapy which cause symptomatic change aids theoretical
understanding of the processes underlying therapeutic change, can improve current practice,
and supports the development of more effective therapies [6]. Several studies have examined
mechanism of change in treatment trials for CFS. A reduction in fear related avoidance of
activity has been shown to mediate the effects of both CBT and GET on fatigue[7], as has a
decrease in focusing on symptoms[8–10] and an increased sense of control over fatigue[9].
Wearden and Emsley [11] showed that reduction in fatigue after pragmatic rehabilitation was
mediated by changes in cognitive and behavioural responses to fatigue, namely reductions in
catastrophizing and self-reported activity limitation. However, a limitation of prior work on
mediators of change is that potential confounding between purported mediators and outcome
has not been addressed, meaning that the purported mediators may merely correlate with,
rather than cause the improvement in outcome [12].
In any psychological intervention, it may be difficult to decide whether outcomes are deter-
mined by specific techniques or mechanisms such as those described above, or, alternatively,
by more general psychological processes such as the therapeutic alliance [13]. It may also be
unclear whether patient or therapist characteristics most determine outcome. Here, will con-
sider two therapist factors which might be related to outcome, therapist effects and therapeutic
alliance.
“Therapist effects” refer to the tendency of different therapists to obtain differential symp-
tomatic change in the patient. Therapists often have allegiances to therapeutic approaches or
superior skills in delivering one particular therapy[14–16], and allegiance effects can be size-
able[16–18]. Reviewing research across all psychological disorders and interventions, Crits-
Christoph and Mintz [19] found that better controlled outcome studies have smaller therapist
effects, suggesting that quality control procedures (manualized therapy, careful selection, train-
ing and supervision of therapists) are successful in minimizing therapist variation. They esti-
mated that therapist effects account for 0% to 50% of change in symptomatic outcome.
To date, three studies have examined therapist effects in chronic fatigue syndrome, with
contrasting results. Two studies used data collected in routine care (not controlled treatment
trials). Wiborg et al. [20] found therapist effects accounted for 21% of variance in post-treat-
ment fatigue. Cella et al. [21] found the therapist effect on outcome accounted for 0% for
fatigue and under 2% for disability, while Godfrey et al. [22], analysing data from a treatment
trial of CBT versus counselling for chronic fatigue, found no detectable therapist effect on out-
come. Wiborg’s finding [20] could be explained by therapists’ attitudes towards a manualized
approach and a centre effect, while Cella’s study [21]took place in a single specialist centre,
using therapists of the same orientation and training, and a shared environment and supervi-
sion for the therapists. In none of these studies were patients randomly assigned to therapists.
Therapeutic alliance refers to the quality of the relationship between therapist and patient
and is commonly accepted to have three components: task, goal and bond [23]. Goals refer
to what the patient hopes to gain from therapy. Tasks are what the patient and therapist
jointly agree need to be completed to reach the patient's goals. The bond forms from trust and
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confidence that the tasks will help the patient achieve the goals. Meta-analytic reviews of
research with patients across a range of therapies and diagnoses consistently claim a good alli-
ance predicts positive outcome across different therapy modalities and different conditions,
with moderate effect sizes [24–26].
Two studies have examined therapeutic alliance in CFS. Heins et al. [27]investigated the
effects of the therapeutic alliance on fatigue, using a definition of the therapeutic relationship
given by Wampold and Budge [28] that included outcome expectations as well as Bordin’s [23]
three components of task, goal and bond. Regressing symptomatic outcome on baseline vari-
ables and the therapeutic relationship, Heins et al. [27] reported that 25% of the variance in
post-treatment fatigue was explained by the therapy relationship as rated by the patient. How-
ever, their reported results (their Table 2) show that that the bond and goal components of
therapeutic alliance did not significantly contribute to the model. The task element of alliance
contributed significantly, but the patients’ expectations explain the most variance. A methodo-
logical limitation of the study was that it used mean imputation to replace missing outcome
data, potentially introducing bias [29]. Godfrey et al. [22] conducted a principal component
analysis of fourteen items measuring therapeutic alliance in the context of a randomized con-
trolled trial of CBT vs counselling delivered by six therapists. Three factors emerged which
were labelled working strategy consensus, therapist contribution and patient contribution. Of
these, only patient contribution significantly correlated with fatigue at 6 months. Subsequent
analysis suggested that a non-alliance measure, ‘emotional processing’, was significantly associ-
ated with a good outcome.
The present paper examines therapist effects and the effect of therapeutic alliance in a sec-
ondary analysis of a randomized controlled trial of treatments for patients with chronic fatigue
syndrome, which has been described and reported elsewhere[5, 30]. The two treatments are
pragmatic rehabilitation and supportive listening, a non-directive counselling based treatment.
Pragmatic rehabilitation was first reported in 2001 [31]. It is an educational self-help treatment
for CFS/ME which starts by providing patients with a detailed explanatory model for their
symptoms, supported by a patient manual containing references to the evidence base. While
pragmatic rehabilitation has aspects in common with cognitive behavioural therapy and graded
exercise therapy, unlike those therapies, it was designed to be delivered by non-specialists
who have been taught the explanatory model. After the presentation of the model, the pro-
gramme of rehabilitation is worked out collaboratively by the patient and the therapist, and is
tailored to the patient’s specific goals, but it always includes a programme of graded increases
in activity.
To enable the present study to be comparable to the larger body of research in psychological
therapies across diagnoses, we use the common definition of therapeutic alliance as including
the task, goal and bond. To enable comparison to the work of Heins et al. [27], the present
study also examines the effect of the task element of alliance separately.
Method
Patients in the FINE Trial were randomized to one of three treatment arms: pragmatic rehabili-
tation (PR) or supportive listening (SL), each delivered with treatment as usual from the gen-
eral practitioner (TAU), or TAU alone. The two active therapies (PR and SL) were delivered by
three general nurses specially trained for the study, with all three nurses delivering both thera-
pies. The three nurses, all female, were all experienced registered nurse practitioners who had
worked in primary care settings for many years, but who did not have a specialist interest in
CFS prior to their employment on the trial. They were not qualified CBT therapists and had
not delivered psychological therapy of this type previously. The nurses received training over a
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six month period in research on CFS, the delivery of the interventions, and working to a proto-
col. Training involved supervised practice, role play and discussions. At the end of training the
nurses’ competence to deliver the interventions was assessed as satisfactory on the basis of their
performance in the practice therapy sessions. The therapists received regular supervision dur-
ing the delivery of the interventions. Fidelity to the treatment approaches was assessed from
randomly selected audiotapes of therapy sessions and was judged to be good by independent
raters.
Randomization was carried out by an independent telephone randomization service based
at the Christie Hospital Clinical Trials Unit in Manchester, using randomised permuted blocks
(with randomly-varying block sizes of 9, 12, 15 or 18), after stratification on two variables—
whether or not the patient was non-ambulatory, defined as using a mobility aid on most days,
and whether or not the patient fulfilled the London criteria for a diagnosis of ME [5, 30]. The
purpose of stratification on ambulatory status and London ME criteria was in order to address
the possibility that those with a higher degree of disability and those who fulfilled the London
ME criteria might be different from the rest of the sample. A randomized assignment of thera-
pist was employed, with patients assigned to therapists in a simple random fashion constrained
only by the availability of the therapists.
One hundred and ninety six participants, aged 18 and over and diagnosed with CFS/ME
using the Oxford criteria [1], were randomized, 95 to PR and 101 to SL. The remaining 100
were randomized to TAU alone, but the TAU group is not included in the current analysis, as
these patients were simply continuing standard contact with their GPs and did not meet a ther-
apist but, more importantly, because they are a common control group for all three therapists,
their data do not contribute any information concerning treatment effect heterogeneity arising
from therapist effects. Patients were excluded from the FINE Trial if they fulfilled diagnostic
criteria for antisocial, borderline, or paranoid personality disorders, had active suicidal idea-
tion, were unable to read or write English, were currently undertaking systematic psychological
therapies for CFS/ME, or had received pragmatic rehabilitation in the past year. Further details
of the FINE trial sample and procedures, and a figure showing participant progression through
the study are available in the main trial protocol and write-up [5, 30]. The FINE study was
granted ethical approval by Eastern MREC (03/05/62). The data were anonymized prior to
analysis. As a secondary analysis of an anonymized and de-identified clinical trial dataset, no
further ethical approval was required for this study.
Measures
Patient Therapeutic Alliance Measure. A brief version of the California Psychotherapeu-
tic Alliance Scale (CALPAS) [32] was completed by patients one week and 10 weeks after the
start of therapy. Patients were asked to complete their forms confidentially at home and return
them to the trial office by post following completion. The scale measured alliance using 5
items, each rated for agreement on an 11 point scale ranging from 0 (not at all) -100 (very
much). Items asked about the therapists’ desire to understand the patient, therapist-patient
agreement on goals, whether the treatment matched the patient’s ideas about helpful treatment
approaches, joint working with the therapist and satisfaction with services received. The scale
total score was the mean score on the five items. Here we present findings from the one week
CALPAS measure only. We also analysed one of the items, measuring task alliance, separately,
to enable comparison with other studies.
Outcome measures. Primary outcomes in the FINE Trial were self-reported physical
functioning, measured using the 8-item physical functioning scale of The Short Form (36)
Health Survey (SF-36) [33] and fatigue, measured using the Chalder fatigue scale [34]. In
Therapist Effects, Therapeutic Alliance and Outcome in CFS
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accordance with usual practice, SF-36 physical functioning scores were calculated from
answers to ten questions about how much the participants health limited their activities, each
question scored 0 (limited a lot), 1 (limited a little), or 2 (not limited at all), then summed and
converted to a percentage. The 11 items of the Chalder fatigue scale ask about problems with
physical and mental fatigue over the past three weeks, and have a response format “less than
usual, no more than usual, more than usual and much more than usual”. Each item may be
scored—either 0011 or 0123, and then the items summed to obtain a total fatigue scale score
[35, 36]. When scored 0011, a score of 4 or more indicated clinically significant levels of
fatigue [34]. Both methods of scoring were used in the present study. Both primary outcomes
were assessed at the end of treatment and one year following the end of treatment (20 and 70
weeks).
Statistical approach. Change scores were calculated for both primary outcomes (fatigue
and physical functioning) by subtracting 20 and 70 week scores from baseline scores from).
First, we examined simple descriptive statistics, by therapist and therapy type (PR vs SL) for
both outcomes and measures of the therapeutic alliance. Since (as a result of the trial design)
the controls are common to all six therapist by therapy type combinations, differences in the
efficacy of these six combinations can be compared without reference to the controls. For
example, the effect of pragmatic rehabilitation when delivered by therapist 1 is the difference in
average outcome for PR delivered by therapist 1 and the average outcome in the controls. The
effect of pragmatic rehabilitation when delivered by therapist 2 is the difference in average out-
come for PR delivered by therapist 2 and the average outcome in the controls. Hence the differ-
ence in efficacy between these two therapists at delivering PR is simply the difference between
the corresponding average outcomes for the two therapists (the average outcome for the com-
mon controls drops out).
To identify whether there is a treatment by therapist interaction we examined whether there
are differences in the therapist effects on outcome, both (i) separately for the two types of treat-
ment, and (ii) for both types of treatment. These were evaluated simultaneously in a regression
(ANCOVA) analysis including the interaction of therapist and treatment. The model was run
for both primary outcomes, fatigue and physical functioning, at both outcome time points. In
line with the trial’s original protocol and write-up, treatment effects were evaluated separately
for the 20- and 70-week outcomes [5, 30].
We then used regression (ANCOVA) models to evaluate whether there were differences in
the average patient-rated therapeutic alliance for the therapists. We compared the therapeutic
alliance levels with the different therapists when they were delivering the two types of treat-
ment, and as a treatment by therapist interaction. We evaluated whether the treatment effects
for outcome were related to the therapist’s average patient-rated therapeutic alliance scores.
The regression model was then repeated using only the task element of alliance to compare to
the work of Heins et al. [27]. If a relationship between the treatment effects and the average
patient-rated therapeutic alliance score for a therapist was found, a causal (instrumental vari-
able) analysis [12] was planned.
In all of the regression models outlined in the preceding two paragraphs, in addition to the
effect of type of intervention, the therapist and their statistical interaction, the regression models
included, as additional covariates, baseline scores of whichever dependent variable was being
regressed. Furthermore, the two variables which were used for stratification of the FINE trial
sample, namely ambulatory status (whether or not the patient used a mobility aid on most days),
and whether the LondonME criteria [37]were met were also included in all of these regression
models. These covariates were included to allow for chance imbalance, control for their effects
and to increase precision; the effects of these covariates are not reported here. The model regress-
ing patient-rated therapeutic alliance scores included the baseline fatigue score as a covariate to
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control for the effect of illness severity, but it did not include baseline therapeutic alliance as it is
not meaningful to measure therapeutic alliance before the patient has met the therapist. Standard
errors and 95% confidence intervals for parameters were calculated using robust (sandwich) esti-
mators, allowing for the effects of possible skewness (lack of normality) in the data[38, 39].
A power calculation was conducted for each regression model using XLSTAT [40] in order
the determine whether we had sufficient power to detect a moderate sized effect. The standard-
ised effect size used was Cohen’s D which provides information about the size of the difference
between two means, taking into account the variability in the data. A Cohen’s D of 0.25 is con-
ventionally considered a moderate effect [41]. Our power calculation revealed that given the
sample size and interactions, we have 0.91 power to detect a moderate effect size (Cohen’s
D = 0.25) in the main intervention effects, and 0.84 power to detect a moderate effect size in
the intervention by therapist interactions, with a 0.05 two-sided significance level. This
research is adequately powered to detect a moderate effect size.
Stata 13.1 [42] was used for all other statistical procedures. Therapists can be modelled as
fixed or random factors. In this report, therapists were modelled as fixed factors as (i) there
were only three therapists, which is too small a sample to generalize to a population of thera-
pists; (ii) the therapists were specially recruited and trained, and so not performing usual
duties, and (iii) a mixed effects model would add unnecessary technical complexity. However,
mixed models which treat therapists as random factors were also run to examine the sensitivity
of the results to this type of model [43].
The trial had missing data in both the treatment outcomes and in measures of the therapeu-
tic alliance. Our analyses considered the likely causes of missing data and how to address
potential bias and lack of precision due to these missing data. The CALPAS had twenty-three
percent missing data in the treated group. Patterns in the missing data were explored and mul-
tiple imputation (MI) was used to deal with potential bias and lack of precision due to missing
data as CALPAS is an intermediate (not baseline or outcome) variable. The number of imputa-
tions should be at least the percentage of cases that are incomplete, so thirty imputations were
added. For missing data in baseline variables, regression imputation was used before MI, as
missing baseline values are independent of randomisation [44]. For missing outcome, weight-
ing was used as MI is not appropriate for missing outcome data in trials [45, 46].
Results
As previously reported [5] the 95 patients randomized to pragmatic rehabilitation had a mean
age of 43.47 years (range 18–68), and 78% were female. The 101 patients randomised to sup-
portive listening had a mean age of 45.13 years (range 21–68) and 79% were female. A fuller
description of the patient samples is provided in the report of the main study [5]. Table 1
shows change in primary outcomes (fatigue and physical functioning) at weeks 20 and 70, as in
the main trial findings [5] but here broken down by therapist. At the end of the treatment
period, patients receiving PR had better outcomes than those receiving SL. Table 1 also shows
patient-rated early alliance with each therapist for each therapy, measured at week one. The
lowest patient-rated alliance was for therapist 3 when delivering SL.
1. Analysis of differences between therapists in the effects on outcome
Table 2 shows the results of the analysis of differences in therapist effects on outcome. The data
were coded so that therapist 1 and SL are the comparison groups in the regression model. The
first row of Table 2 (labelled therapist 2) is the therapist effect on fatigue (0011 scoring method)
when therapist 2 delivered SL compared to when therapist 1 delivered SL. The second row is
similarly defined. There are no significant therapist effects in the delivery of SL. The third row,
Therapist Effects, Therapeutic Alliance and Outcome in CFS
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labelled ‘therapy’, is the effect on outcome when therapist 1 delivered PR compared to when
therapist 1 delivered SL. For therapist 1, PR was significantly more effective than SL at 20
weeks but not 70 weeks.
This analysis was repeated for fatigue (0123 scoring method) and physical functioning, as
shown in Table 2. The results are consistent. Patients in receipt of PR fare significantly better
than patients in receipt of SL at 20 weeks, but the difference is no longer significant at the 70
week outcome. In the main trial results [4], randomisation to PR only had a significant effect
on the Chalder fatigue scale at 20 weeks when the fatigue scale was scored 0011. Readers should
note that the analysis reported in this paper compares two therapies, delivered by different
therapists, in contrast to the main trial results [4], which compared each therapy to GP treat-
ment as usual. Therapist effects are not significant.
Simple one-way analysis of variance models provided estimates of the proportion of vari-
ance in outcomes which is associated with the therapist (intra-class correlations, see Table 3).
For fatigue scored 0123 at 70 weeks, intraclass correlations were 0.10 and -0.10 for PR and SL,
respectively. For physical functioning, there were intraclass correlations of 0.05 and -0.01 for
PR and SL, respectively suggesting that differences between therapists accounted for little of
the variance in outcomes.
2. Analysis of differences in therapeutic alliance between therapists
Table 3 shows that there was a significant main effect of therapist and a significant interac-
tion between therapist and therapy on the patient-rated CALPAS total score and on the
Table 1. Mean (SD) changes in fatigue and physical functioning and therapeutic alliance, by therapy and by therapist.
Pragmatic Rehabilitation mean (SD), % missing Supportive Listening mean (SD), % missing
Therapist
1n = 34
Therapist
2n = 29
Therapist
3n = 32
Therapist
1n = 32
Therapist
2n = 35
Therapist
3n = 34
CALPAS Total 82.78 (14.42),
32.4
75.91 (23.80),
24.1
85.92 (17.68),
21.9
82.63 (14.33),
40.6
75.25 (14.64),
42.9
67.28 (18.63),
26.5
Post-MI CALPAS Total 82.28 (15.79), - 76.27 (23.03), - 85.52 (17.53), - 80.81 (14.99), - 75.97 (16.75), - 64.92 (19.49), -
CALPAS Task Element 63.81 (26.36),
34.4
53.33 (25.31),
31.5
46.90 (22.06),
14.7
69.13 (23.14)),
32.4
67.73 (30.54),
24.1
76.00 (22.55),
21.9
Post-MI CALPAS Task Element 64.98 (26.20), - 55.94 (25.89), - 45.40 (22.12), - 67.11 (23.75), - 67.12 (29.42), - 75.34 (22.50), -
20 week outcomes
Δ Chalder Fatigue (scored
0011)
-2.63 (3.78), 8.8 -2.25 (3.53), 17.2 -1.26 (2.75), 15.6 -0.52 (2.40), 9.4 -0.81 (2.65), 5.7 -1.18 (3.06), 0.0
Δ Chalder Fatigue (scored
0123)
-7.53 (9.40), 8.8 -6.58 (7.65), 17.2 -5.78 (7.18), 15.6 -1.48 (6.52), 9.4 -2.84 (7.31), 5.7 -3.06 (6.29), 0.0
Δ SF-36 Physical Functioning
Scale
+2.00 (3.93), 8.8 +2.52 (3.86),
13.8
+1.69 (4.29), 9.4 +0.34 (3.03), 9.4 +0.22 (4.66), 8.6 +0.85 (3.10), 2.9
70 week outcomes
Δ Chalder Fatigue (scored
0011)
-1.67 (3.56), 14.7 -3.18 (4.27), 24.1 -0.80 (2.75), 21.9 -1.43 (3.44), 12.5 -1.14 (2.83), 17.1 -1.27 (3.16), 8.8
Δ Fatigue (scored 0123) -6.15 (8.88), 14.7 -7.55 (8.20), 24.1 -3.20 (6.71), 21.9 -3.04 (8.63), 12.5 -3.50 (8.23), 17.1 -2.63 (7.23), 8.8
Δ SF-36 Physical Functioning
Scale
+2.57 (4.01),
14.7
+3.50 (3.77),
17.2
+2.04 (3.77),
15.6
+1.17 (3.91), 9.4 +1.24 (5.04),
17.1
+0.69 (3.88), 5.9
Δ represents change in score from baseline to outcome, calculated by subtracting baseline scores from outcome scores.
Reductions in the Fatigue scale indicate improvement. Increases in the SF-36 Physical Functioning scale indicate improvement. A higher CALPAS score
indicates stronger alliance. All CALPAS measures are at week 1. ‘Post-MI’ means post multiple imputation.
doi:10.1371/journal.pone.0144623.t001
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CALPAS task element. The significant main effect is due to the lower level of patient-rated
early therapeutic alliance when SL was delivered by therapist 3 compared to when SL was
delivered by therapist 1. The significant interaction is the difference in level of therapeutic
alliance when therapist 3 delivered PR compared to when therapist 1 delivered SL. Interpret-
ing main effects in the presence of a statistically significant interaction requires caution.
Inspecting the table of means (Table 1) reveals that for therapist 3, higher CALPAS values
were obtained when delivering PR than when delivering SL. This accounts for both the main
effect and interaction effect observed on the CALPAS scores. The results for the ‘task agree-
ment’ element of therapeutic alliance exactly echo the results for the full therapeutic alliance,
and have the same interpretation.
Table 3. Intraclass Correlation Coefficients (ICCs) between ratings of therapeutic alliance (across three therapists) in the pragmatic rehabilitation
and supportive listening conditions, and change in fatigue and physical functioning at 20 and 70 weeks.
Pragmatic Rehabilitation Coefﬁcient Supportive Listening Coefﬁcient
20 week outcomes
Chalder Fatigue (scored 0011) 0.03 -0.08
Chalder Fatigue (scored 0123) 0.01 -0.07
SF-36 Physical Functioning Scale 0.02 -0.12
70 week outcomes
Chalder Fatigue (scored 0011) 0.11 -0.38
Chalder Fatigue (scored 0123) 0.10 -0.10
SF-36 Physical Functioning Scale 0.05 -0.01
doi:10.1371/journal.pone.0144623.t003
Table 2. Regression analyses of therapist effects on primary outcomemeasures.
20 weeks 70 weeks
Chalder Fatigue (scored 0011) Coefﬁcient SE P 95% CI Coefﬁcient SE p 95% CI
Therapist 2 -0.50 0.71 0.48 -1.90 to 0.91 0.38 0.89 0.67 -1.38 to 2.14
Therapist 3 -0.72 0.70 0.31 -2.10 to 0.66 0.25 0.90 0.78 -1.53 to 2.02
Therapy (effect of PR compared to SL in therapist 1) -2.28 0.83 0.006 -3.91 to -0.65 -0.23 0.90 0.80 -2.00 to 1.54
Interaction of therapist 2 and PR 1.00 1.21 0.41 -1.39 to 3.40 -2.18 1.41 0.12 -4.96 to 0.61
Interaction of therapist 3 and PR 2.16 1.11 0.06 -0.03 to 4.35 0.76 1.20 0.53 -1.61 to 3.13
halder Fatigue (scored 0123)
Therapist 2 -0.96 1.75 0.58 -4.42 to 2.49 0.13 2.21 0.95 -4.23 to 4.48
Therapist 3 -1.17 1.56 0.46 -4.24 to 1.91 0.89 2.09 0.67 -3.25 to 5.03
Therapy (effect of PR compared to SL in therapist 1) -5.97 1.99 0.003 -9.90 to -2.03 -3.34 2.07 0.11 -7.44 to 0.75
Interaction of therapist 2 and PR 2.32 2.89 0.43 -3.40 to 8.03 -1.59 3.31 0.63 -8.12 to 4.93
Interaction of therapist 3 and PR 3.85 2.62 0.15 -1.34 to 9.03 3.37 2.82 0.23 -2.20 to 8.94
SF-36 Physical Functioning Scale
Therapist 2 -0.21 0.91 0.82 -2.01 to 1.60 -0.10 1.12 0.93 -2.32 to 2.12
Therapist 3 0.49 0.73 0.50 -0.95 to 1.93 -0.56 0.90 0.54 -2.33 to 1.22
Therapy (effect of PR compared to SL in therapist 1) 1.80 0.87 0.04 0.08 to 3.51 1.10 1.15 0.34 -1.17 to 3.38
Interaction of therapist 2 and PR 0.19 1.42 0.90 -2.63 to 3.00 1.10 1.76 0.54 -2.38 to 4.58
Interaction of therapist 3 and PR -1.47 1.26 0.24 -3.96 to 1.01 0.009 1.51 0.995 -2.98 to 3.00
Note that reductions in the Chalder Fatigue scale indicate improvement. Increases in the SF-36 Physical Functioning scale indicate improvement.
doi:10.1371/journal.pone.0144623.t002
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3. Is there any evidence of a relationship between TA and treatment
effect?
Comparison of the significant effects in the regression models for the effects on outcome
(Table 2) to the regression models for the therapeutic alliance (see Table 4) reveals that there is
a different pattern of significant effects in the two models. This suggests that the component(s)
which caused the significant difference in treatment effects (Therapist 1, PR vs SL) are not
related to therapeutic alliance.
All analyses were repeated with mixed effects regression models which treat therapists as
random factors. In addition, we ran regression models which were ‘complete case’ analyses;
ignoring the missing data. Both of these supplementary sets of analyses gave results which were
consistent with the models presented in this paper, and increased our confidence in the models
presented.
Discussion
We found no evidence that either therapist effects or therapeutic alliance significantly pre-
dicted changes in the two primary outcomes, fatigue and physical functioning, in a randomized
controlled trial. The power calculation revealed that we had adequate power to detect effects of
moderate size. Inspection of a table of correlations between therapeutic alliance and changes in
outcomes, for each therapy and for each therapist at each assessment point revealed no consis-
tent pattern of correlations (data in S1 Table). On this basis, it seems likely that the relationship
between therapist effects, therapeutic alliance and outcome is not present in this study, rather
than a lack of statistical power accounting for the results.
It is unusual, although not unknown, to find no therapist effects or effects of therapeutic alli-
ance in trials of psychological or behavioural therapies. Perry and Howard (1989, cited in [17])
suggest therapist experience may be a critical factor, and that a sample of highly experienced
therapists may yield significant variability on symptomatic outcome, whereas a sample con-
taining less experienced therapists may yield more obvious therapist effects (up to 50% of out-
come variance). The nurses used in the FINE trial were experienced primary care practitioners
but prior to training were inexperienced in delivering therapy for CFS, and inexperienced at
working within the confines of a research protocol. They were recruited specially to deliver the
interventions in the FINE Trial, and all received identical training in both the delivery of the
interventions and working to a protocol. Training involved supervised practice, role play and
discussions, and the therapists received regular supervision during the time they were deliver-
ing the intervention. At the end of training all the therapists were considered competent to
deliver the interventions. Fidelity to the treatment approaches was judged good by independent
Table 4. Regression analyses of the effect of therapy and therapist on mean patient-rated therapeutic alliance. Models for both the CALPAS and
CALPAS Task element are shown.
CALPAS CALPAS Task Element
Coefﬁcient SE P 95% CI Coefﬁcient SE p 95% CI
Therapist 2 -8.47 4.93 0.09 -18.22 to 1.28 -10.40 7.26 0.15 -24.76 to 3.96
Therapist 3 -15.94 4.99 0.002 -25.82 to -6.06 -17.52 6.72 0.01 -30.81 to -4.22
Therapy (effect of PR compared to SL in therapist 1) -0.72 4.63 0.88 -9.89 to 8.45 2.23 7.22 0.76 -12.08 to 16.54
Interaction of therapist 2 and PR 1.94 7.62 0.80 -13.14 to 17.02 10.38 10.39 0.32 -10.17 to 30.93
Interaction of therapist 3 and PR 18.91 7.03 0.008 5.00 to 32.82 24.24 9.41 0.01 5.62 to 42.85
Note that a higher CALPAS score indicates stronger alliance.
doi:10.1371/journal.pone.0144623.t004
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raters. It is possible therefore, that although prior to training we had three inexperienced thera-
pists, at the end of training and during intervention delivery, we actually had three therapist
who were closely matched for competence, and with similar approaches to patients. Our find-
ings are in contrast to the findings of Wiborg et al.[20]. In Wiborg’s study, therapists were
recruited from existing services. Therapist variation on symptomatic outcome was attributed
to variation in therapists’ attitudes towards a manualised approach to treatment delivery. We
did not measure therapists’ attitudes to the two interventions in the present study. Our thera-
pists were not in the position of having to adjust prior practice to meet the demands of a
research trial setting.
Godfrey et al. [22] observed significantly higher alliance scores when therapists delivered
CBT compared to when delivering counselling. The authors, who used a fuller version of the
CALPAS scale than the one we used, suggested that this may be due to an artefact of the CAL-
PAS items selected, which included more technically than interpersonally focussed elements
of therapy. The PACE trial [2] found no difference in the level of therapeutic alliance across
treatment groups. In the FINE trial, the patient-rated early therapeutic alliance scores were,
on average, higher when participants received PR (which has similarities to CBT), than when
they received SL. However, this effect was only significant for therapist three. For therapists
one and two, the differences in the mean alliance formed when delivering PR compared to SL
were small. Comparison to other studies [2, 23, 27] suggested that the therapeutic alliance
scores were typical for this patient group; meaning the results of the present study cannot be
explained by unusually high or low alliances being formed.
No prior research in this area has randomized the allocation of therapist. The effects
observed in prior research where patients were not randomized to therapists may be a mixture
of treatment and selection effects. It is possible that in our study, by randomizing the therapist,
we eliminated selection effects. Additionally, ours was a well-conducted study with adequate
safeguards against sources of bias. Crits-Christoph and Mintz [19] found that studies with high
quality control showed reduced therapist variation. It is possible that a combination of the use
of high quality control and randomisation of therapists eliminated therapist effects in the pres-
ent study. Whether it would be feasible or desirable to try to eliminate therapist effects in stan-
dard clinical practice is less clear. Attempts to standardise treatment delivery to more closely
resemble the conditions of a controlled clinical trial might be difficult in clinical practice when
therapists have a variety of priorities and calls on their time. Experienced therapists may not
wish to alter aspects of their practice and mode of delivery of therapy which had worked for
them over the years. It would be necessary to ensure that the most effective therapeutic tech-
niques were combined with a standardised best therapist practice. Probably a more feasible
approach would be to develop clearly defined and measurable therapist competencies[47] and
to ensure through appointment procedures and clinical supervision that therapists were able to
operate in accordance with these competencies. A further consideration is that, in a service
with many patients and many therapists, there may be some scope for matching patients to
therapists on individual characteristics, such as attachment style.
It may be the case that therapist effects and therapeutic alliance are of relatively limited
importance in determining outcomes after treatment for chronic fatigue syndrome. There is
growing evidence that the factors which mediate change after CBT and GET are changes in
cognitive and behavioural factors such as symptom focusing, catastrophizing, and fear driven
avoidance of activity[7, 9–11]. In the FINE Trial decreases in catastrophizing and self-reported
activity limitation mediated change in fatigue following PR [11]. It is possible that these factors
will change whenever treatments such as CBT, GET and PR are delivered competently. Sup-
portive listening was not an effective treatment in the FINE Trial.
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A key feature of this research was the random allocation of patients to therapists, thus
excluding confounding factors such as location, or tendency to work with a particular subgroup
of clients, in the analysis of therapist effects. This is a highly unusual feature of these data and a
major strength. The sample size is large. Modern and statistically valid methods of dealing with
missing data were used, including regression imputation for missing baseline data, multiple
imputation for missing post-randomisation variables, and weighting for missing outcome data.
Our confidence in our findings is increased by the fact that different statistical models all indi-
cate the same results [43]. The standard deviation for the number of sessions attended is small
(most individuals had close to the full treatment). In the SL arm, the mean number of sessions
was 9.5 (S.D. 0.8), and in the PR arm, the mean number of sessions was 9.6 (S.D. 0.9) [5]. This
reduces the effect of noncompliance from the randomized protocol in this analysis.
A limitation of the study is that the conclusion is potentially only valid for the range of
recorded alliance levels, and that alliance was measured at the end of the first therapy session,
which may have been too early for the therapeutic relationship to have formed. A small sample
of only three therapists were used, which limits our ability to detect therapist effects, but is less
important for the effect of therapeutic alliance on outcomes. While PR was effective in reducing
fatigue in the FINE Trial, when compared with GP treatment as usual, neither PR nor SL signif-
icantly improved physical functioning, and there was little change in this outcome variable.
This may reduce the likelihood of finding therapist effects or an effect of therapeutic alliance.
Conclusions
The different therapists in the trial did not tend to form significantly different levels of alliance
with clients, apart from therapist three when delivering PR compared to when delivering SL.
Analysis of the outcomes did not indicate any significant therapist effects for change in physical
functioning or fatigue at either 20 or 70 weeks; all therapists delivered both treatments at com-
parable levels of effectiveness. Furthermore, our analysis suggests that when specially trained
nurse therapists delivered pragmatic rehabilitation or supportive listening at home to people
with CFS/ME, the level of therapeutic alliance did not influence the effectiveness of treatment.
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